Agios Pharmaceuticals | AGIO - 净收入

股票价格
32.73
每天变化
-1.04 -3.08%
每月一次
15.82%
每年
29.32%
Q2 预测
34.14


金融业
股票价格
USD
资产
USD 1.3B
现金及等价物
USD 89.13M
销售成本
USD 1.88M
流动资产
USD 942.05M
流动负债
USD 82.21M
债务
USD 44.52M
EBIT
USD -121.58M
EBITDA
USD -115.5M
员工
486
EPS每股收益
USD -1.86
股本和储备
USD 1.19B
销售毛利
USD 18.09M
债务利息支出
USD 1.39B
利息收入
USD 13.37M
贷款资金
USD 1.06M
市值
USD 1.89B
净收入
USD -108.04M
营业费用
USD 141.55M
营业利润
USD -121.58M
普通股股本
USD 58.45M
PE价格收益
3.56
税前利润
USD -109.06M
销售收入
USD 19.97M
销售和管理费用
USD 42.97M
股票
USD 32.92M
贸易债权人
USD 18.36M
应收帐款人
USD 10.58M


净收入 更改 日
AbbVie USD 1.82B 1.63B 2025-12
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Astellas Pharma JPY 100.38B 21.17B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Exelixis USD 193.58M 8.73M 2025-09
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 2.41B 1.52B 2025-12
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12